This article has been updated with information and comments from Foundation Medicine's earning call.

NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Wednesday that its fourth quarter revenues climbed 11 percent, driven by strong growth from its biopharmaceutical business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.